马应龙药业集团股份有限公司2025年第三季度报告

Core Viewpoint - The company announced the cancellation of its supervisory board and the revision of its articles of association to optimize its governance structure and enhance governance efficiency [8][9]. Financial Data - The financial statements for the third quarter are unaudited, and the company has provided key financial data and indicators in RMB [3][7]. - The report indicates that there were no significant changes in the financial indicators or major accounting data during the reporting period [5]. Corporate Governance Changes - The company plans to abolish the supervisory board and has proposed amendments to its articles of association, which will be submitted for approval at the shareholders' meeting [8]. - The company has also revised and formulated certain governance systems to ensure compliance with relevant laws and regulations [9].